| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 02, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$47.00
Est. +153%
|
$18.59 | $19.43 |
Pending
|
$15.34
-17.5%
|
| Jun 02, 2026 |
Merck & Co Inc
MRK
|
BUY |
$140.00
Est. +22%
|
$115.21 | $123.51 |
Pending
|
$114.90
-0.3%
|
| May 08, 2026 |
Insmed Inc
INSM
|
BUY |
$226.00
Est. +115%
|
$105.00 | $122.94 |
Pending
|
$97.46
-7.2%
|
| Apr 10, 2026 |
Abbvie Inc
ABBV
|
BUY |
$249.00
Est. +18%
|
$210.15 | $230.47 |
Pending
|
$221.59
+5.4%
|
| Jan 23, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$240.00
Est. +10%
|
$218.49 | $251.61 |
Target Met
|
$235.66
+7.9%
|
| Jan 16, 2026 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$124.00
Est. +45%
|
$85.29 | $87.76 |
Pending
|
$82.29
-3.5%
|
| Jan 14, 2026 |
Travere Therapeutics Inc
TVTX
|
BUY |
$49.00
Est. +73%
|
$28.39 | $53.88 |
Target Met
|
$53.80
+89.5%
|
| Dec 01, 2025 |
Evolus Inc
EOLS
|
BUY |
$19.00
Est. +179%
|
$6.82 | $7.34 |
Pending
|
$6.75
-1.0%
|
| Sep 08, 2025 |
ANI Pharmaceuticals Inc
ANIP
|
BUY |
$114.00
Est. +20%
|
$95.20 | $99.50 |
Pending
|
$82.29
-13.6%
|
| Jun 16, 2025 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$14.00
Est. +107%
|
$6.76 | $27.96 |
Target Met
|
$15.34
+126.9%
|
| Mar 24, 2025 |
Valneva SE - ADR
VALN
|
BUY |
$15.00
Est. +102%
|
$7.43 | $12.25 |
Miss
|
$5.39
-27.5%
|
| Feb 03, 2025 |
Johnson & Johnson
JNJ
|
BUY |
$166.00
Est. +9%
|
$151.87 | $231.19 |
Target Met
|
$235.66
+55.2%
|
| Nov 13, 2024 |
Alkermes plc
ALKS
|
BUY |
$40.00
Est. +53%
|
$26.07 | $36.45 |
Miss
|
$44.36
+70.2%
|
| Oct 30, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$10.00
Est. +27%
|
$7.86 | $9.36 |
Miss
|
$8.68
+10.4%
|
| Sep 27, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$23.00
Est. +53%
|
$15.04 | $28.69 |
Target Met
|
$53.80
+257.7%
|
| Sep 23, 2024 |
Keros Therapeutics Inc
KROS
|
BUY |
$96.00
Est. +72%
|
$55.80 | $72.37 |
Miss
|
$10.24
-81.6%
|
| Sep 17, 2024 |
Revance Therapeutics Inc
RVNC
|
BUY |
$6.66
Est. +12%
|
$5.96 | $6.30 |
Miss
|
$3.65
-38.8%
|
| Sep 13, 2024 |
Evolus Inc
EOLS
|
BUY |
$25.00
Est. +52%
|
$16.46 | $17.82 |
Miss
|
$6.75
-59.0%
|
| Sep 09, 2024 |
ExlService Holdings Inc
EXLS
|
SELL |
$25.00
Est. +31%
|
$36.18 | $35.52 (Low) |
Miss
|
$28.41
+21.5%
|
| Sep 09, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$25.00
Est. +98%
|
$12.62 | $25.29 |
Precision Hit (±3%)
|
$53.80
+326.3%
|
| Jul 30, 2024 |
Pfizer Inc.
PFE
|
BUY |
$36.00
Est. +17%
|
$30.72 | $31.54 |
Miss
|
$26.00
-15.4%
|
| Jul 09, 2024 |
Insmed Inc
INSM
|
BUY |
$95.00
Est. +36%
|
$70.05 | $106.83 |
Target Met
|
$97.46
+39.1%
|
| Jun 27, 2024 |
Savara Inc
SVRA
|
BUY |
$10.00
Est. +421%
|
$1.92 | $5.11 |
Miss
|
$5.33
+177.6%
|
| May 10, 2024 |
Revance Therapeutics Inc
RVNC
|
BUY |
$8.00
Est. +114%
|
$3.73 | $6.65 |
Miss
|
$3.65
-2.1%
|
| Apr 17, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$20.00
Est. +65%
|
$12.11 | $13.46 |
Miss
|
$8.68
-28.3%
|
| Apr 11, 2024 |
GSK Plc - ADR
GSK
|
SELL |
$36.00
Est. +12%
|
$40.69 | $31.72 (Low) |
Target Met
|
$52.23
-28.4%
|
| Apr 09, 2024 |
Alkermes plc
ALKS
|
BUY |
$35.00
Est. +31%
|
$26.73 | $36.45 |
Target Met
|
$44.36
+66.0%
|
| Apr 09, 2024 |
Alpine Immune Sciences Inc
ALPN
|
BUY |
$55.00
Est. +43%
|
$38.53 | $65.00 |
Target Met
|
$64.97
+68.6%
|
| May 09, 2023 |
Abbvie Inc
ABBV
|
BUY |
$171.00
Est. +16%
|
$147.01 | - | - |
$221.59
+50.7%
|
| May 03, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$356.00
Est. +23%
|
$289.56 | - | - |
$1,129.59
+290.1%
|
| May 02, 2022 |
Pfizer Inc.
PFE
|
BUY |
$55.00
Est. +12%
|
$49.07 | - | - |
$26.00
-47.0%
|
| Feb 06, 2022 |
Abbvie Inc
ABBV
|
BUY |
$166.00
Est. +18%
|
$140.65 | - | - |
$221.59
+57.5%
|